14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $133.39 $156.84 Thursday, 2nd May 2024 ASND stock ended at $141.10. This is 0.0638% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.40% from a day low at $139.26 to a day high of $143.99.
90 days $133.39 $161.00
52 weeks $83.75 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Jan 14, 2022 $119.05 $128.49 $116.79 $122.96 246 300
Jan 13, 2022 $123.00 $128.04 $118.34 $119.05 488 200
Jan 12, 2022 $118.90 $122.63 $117.19 $121.85 245 100
Jan 11, 2022 $116.07 $122.77 $116.07 $118.88 205 100
Jan 10, 2022 $114.86 $116.78 $111.96 $116.18 281 600
Jan 07, 2022 $121.18 $122.17 $116.33 $116.86 123 900
Jan 06, 2022 $121.45 $123.80 $117.10 $121.70 178 600
Jan 05, 2022 $131.25 $133.29 $121.58 $123.37 328 000
Jan 04, 2022 $135.67 $135.94 $127.93 $132.96 243 567
Jan 03, 2022 $134.62 $137.40 $131.49 $135.75 144 585
Dec 31, 2021 $136.41 $138.00 $132.00 $134.53 165 256
Dec 30, 2021 $132.95 $139.93 $132.76 $136.41 132 297
Dec 29, 2021 $134.16 $136.73 $131.05 $133.75 115 539
Dec 28, 2021 $138.46 $140.12 $133.41 $134.68 119 820
Dec 27, 2021 $136.93 $139.60 $135.80 $138.46 102 020
Dec 23, 2021 $139.50 $140.14 $134.82 $139.32 97 537
Dec 22, 2021 $138.24 $143.09 $137.41 $139.03 194 720
Dec 21, 2021 $135.12 $140.63 $134.82 $138.64 219 022
Dec 20, 2021 $130.63 $137.17 $128.93 $134.39 206 619
Dec 17, 2021 $125.83 $133.24 $125.00 $132.39 355 265
Dec 16, 2021 $134.13 $138.81 $127.10 $127.10 529 215
Dec 15, 2021 $136.64 $138.05 $131.15 $134.15 492 386
Dec 14, 2021 $139.33 $142.38 $136.20 $136.64 263 108
Dec 13, 2021 $139.99 $144.25 $137.91 $140.11 278 887
Dec 10, 2021 $140.71 $142.82 $138.30 $140.00 303 815
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT